Company Filing History:
Years Active: 2006-2010
Title: The Innovations of Gholamreza Haqshenas
Introduction
Gholamreza Haqshenas is an accomplished inventor based in Tehran, Iran. With a significant portfolio encompassing three patents, he has made notable contributions to the field of virology, particularly in relation to avian and mammalian hepatitis E viruses.
Latest Patents
Haqshenas's most recent patents focus on the development of a novel isolated avian hepatitis E virus. This invention includes a detailed nucleotide sequence set forth in SEQ ID NO:1 or its complementary strand. His work also covers immunogenic compositions that include this new virus, along with vaccines designed to protect avian and mammalian species from viral infections and hepatitis-splenomegaly syndrome caused by the hepatitis E virus.
Additionally, his inventions describe a method for propagating, inactivating, or attenuating the hepatitis E virus. This method involves inoculating an embryonated chicken egg with live, pathogenic hepatitis E virus, followed by recovering or serially passing the virus through more embryonated eggs until it is rendered inactive or attenuated. Furthermore, his patents include diagnostic reagents for detecting avian hepatitis E viral infections, along with advanced methods utilizing nucleic acid hybridization probes or oligonucleotide primers for polymerase chain reaction (PCR).
Career Highlights
Haqshenas works with Virginia Tech Intellectual Properties, Inc., where he applies his expertise in virology and innovation. His dedication to research has allowed him to develop significant advancements in vaccine and diagnostic reagent technology.
Collaborations
Throughout his career, Haqshenas has collaborated with notable colleagues, including Xiang-Jin Meng and Fang-Fang Huang. These partnerships underscore the importance of teamwork in the successful development of innovative solutions in the scientific community.
Conclusion
Gholamreza Haqshenas stands out as a pioneering inventor in the realm of hepatitis E research. His contributions continue to play a vital role in developing vaccines and diagnostic tools that can significantly impact avian and mammalian health.